Physician profile
David M Stark
NPI 1730115908
$4,063.08
in general payments reported to CMS, 2019-2025
15 companies · $351 in 2025
The $351 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $12.88 · 2021: $193 · 2022: $1,455 · 2023: $331 · 2024: $1,612 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,272 · Travel and Lodging: $886 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,271.70 |
| Travel and Lodging | $885.78 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,686.90 | 2022-2024 | |
| Arthrex, INC. | $1,199.68 | 2024 | |
| Globus Medical, INC. | $259.79 | 2023 | Distal Radius Plate |
| Medical Device Business Services, INC. | $250.85 | 2025 | Vistaseal |
| Pacira Therapeutics, INC. | $146.22 | 2019-2021 | |
| Smith+Nephew, INC. | $130.93 | 2021 | |
| Zimmer Biomet Holdings, INC. | $105.79 | 2022 | |
| Depuy Synthes Sales INC. | $49.97 | 2024 | Monovisc, Speedtrap, Truespan Orthocord |
| Abbott Laboratories | $46.87 | 2022-2023 | Octrode |
| Vertex Pharmaceuticals Incorporated | $40.47 | 2025 | |
| Collegium Pharmaceutical, INC. | $36.89 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $36.26 | 2025 | Exparel, Zilretta, Iovera |
| Bioventus LLC | $24.87 | 2023 | Durolane |
| Boston Scientific Corporation | $23.82 | 2025 | Avvigo Guidance System |
| Innovation Technologies INC | $23.77 | 2023 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Stark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.